Finance

Lists
TRVI:NASDAQ
Trevi Therapeutics Inc
13,73 US$
-1,29%
(-0,18) 1D
5 ოქტ, 15:45:50 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRVI...
Open
13,97 US$
High
14,11 US$
Low
13,51 US$
Mkt. cap
1,96 მლრდ.
Avg. vol.
1,65 მლნ.
Volume
1,06 მლნ.
52-wk high
20,15 US$
52-wk low
9,29 US$
EPS
-0,34 US$
Beta
0,98
Shares outstanding
142,48 მლნ.
No. of employees
34
Open
13,97 US$
High
14,11 US$
Low
13,51 US$
Mkt. cap
1,96 მლრდ.
Avg. vol.
1,65 მლნ.
Volume
1,06 მლნ.
52-wk high
20,15 US$
52-wk low
9,29 US$
EPS
-0,34 US$
Beta
0,98
Shares outstanding
142,48 მლნ.
No. of employees
34
News stories
From web sources and news partners
About Trevi Therapeutics Inc
CEO-
Employees34
Founded2011
Headquartersნიუ-ჰეივენი, კონექტიკუტი, ამერიკის შეერთებული შტატები
SectorPharmaceutical industry
Websitetrevitherapeutics.com
Analyst ratings
Based on 10 analysts giving stock ratings to TRVI in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TRVI in the last 3 months.
Highest
Current 13,73 US$
40,00 US$ (+191,33%)
Average
29,00 US$ (+111,22%)
Lowest
23,00 US$ (+67,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Brandon Folkes
H.C. Wainwright
Buy
Maintained
24,00 US$
+74,8%
09/21/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
28,00 US$
+103,9%
08/13/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
23,00 US$
+67,5%
08/10/2026
Serge Belanger
Needham
Buy
Maintained
23,00 US$
+67,5%
08/07/2026
Ryan Deschner
Raymond James
Buy
Maintained
40,00 US$
+191,3%
08/07/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
31,00 US$
+125,8%
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
30,00 US$
+118,5%
08/06/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
25,00 US$
+82,1%
08/07/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
30,00 US$
+118,5%
08/07/2026
Conor MacKay
BMO Capital
Buy
Initiated
36,00 US$
+162,2%
07/21/2026
Evan Seigerman
BMO Capital
Buy
Initiated
36,00 US$
+162,2%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
36,00 US$
+162,2%
07/20/2026
William Wood
B. Riley Securities
Buy
Reiterated
31,00 US$
+125,8%
07/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
29,00 US$
+111,2%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10,08 მლნ.
6,19 მლნ.
9,94 მლნ.
15,15 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,83 მლნ.
4,03 მლნ.
4,97 მლნ.
5,36 მლნ.
Operating expense
13,92 მლნ.
10,22 მლნ.
14,91 მლნ.
20,51 მლნ.
Total operating expenses
13,92 მლნ.
10,22 მლნ.
14,91 მლნ.
20,51 მლნ.
Operating income
-13,92 მლნ.
-10,22 მლნ.
-14,91 მლნ.
-20,51 მლნ.
Other non operating income
-2,00 ათ.
-15,00 ათ.
-
-
EBT including unusual items
-11,82 მლნ.
-8,33 მლნ.
-13,21 მლნ.
-17,82 მლნ.
EBT excluding unusual items
-11,82 მლნ.
-8,33 მლნ.
-13,21 მლნ.
-17,82 მლნ.
Income tax expense
-15,00 ათ.
-16,00 ათ.
-20,00 ათ.
-19,00 ათ.
Effective tax rate
0,13%
0,19%
0,15%
0,11%
Other operating expenses
-
-
-
-
Net income
-11,80 მლნ.
-8,32 მლნ.
-13,19 მლნ.
-17,80 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,08
-0,06
-0,09
-0,11
Interest and investment income
2,10 მლნ.
1,90 მლნ.
1,70 მლნ.
2,70 მლნ.
Interest expense
-
-
-
-
Net interest expenses
2,10 მლნ.
1,90 მლნ.
1,70 მლნ.
2,70 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,88 მლნ.
-10,19 მლნ.
-14,88 მლნ.
-20,48 მლნ.
Gain or loss from assets sale
-
7,00 ათ.
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები